Sun Pharma’s consolidated net profit falls 36% in Q2

The company has reported 54.42% jump in its net profit at Rs 871.29 crore for the quarter ended September 30, 2026 as compared to Rs 564.22 crore for the same quarter in the previous year. The total income of the company has increased by 34.67% at Rs 6,222.93 crore for Q2FY27 as compared to Rs 4,620.90 crore for the corresponding quarter of the previous year. ​On consolidated basis, the company has reported 36.22% decline in its net profit at Rs 1,988.53 crore for the quarter ended September 30, 2026 as compared to Rs 3,117.95 crore for the same quarter in the previous year. However, total income of the company increased by 11.83% at Rs 16,716.03 crore for Q2FY27 as compared to Rs 14,948.23 crore for the corresponding quarter previous year.

Disclosure: I do not hold any position in the mentioned stock. This is only for educational purpose.